nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—CYP2C9—brain cancer	0.62	1	CbGaD
Epinephrine—CYP1A2—Carmustine—brain cancer	0.0471	0.351	CbGbCtD
Epinephrine—CYP3A4—Temozolomide—brain cancer	0.0356	0.265	CbGbCtD
Epinephrine—CYP3A4—Lomustine—brain cancer	0.0303	0.226	CbGbCtD
Epinephrine—CYP1A2—Etoposide—brain cancer	0.014	0.104	CbGbCtD
Epinephrine—CYP3A4—Etoposide—brain cancer	0.00731	0.0545	CbGbCtD
Epinephrine—Skin necrosis—Hydroxyurea—brain cancer	0.00409	0.0396	CcSEcCtD
Epinephrine—Extravasation—Carboplatin—brain cancer	0.00381	0.0369	CcSEcCtD
Epinephrine—Contusion—Lomustine—brain cancer	0.00334	0.0323	CcSEcCtD
Epinephrine—Skin necrosis—Carmustine—brain cancer	0.00331	0.032	CcSEcCtD
Epinephrine—Hemiplegia—Carmustine—brain cancer	0.00324	0.0313	CcSEcCtD
Epinephrine—Hemiplegia—Temozolomide—brain cancer	0.00313	0.0303	CcSEcCtD
Epinephrine—Skin necrosis—Etoposide—brain cancer	0.00256	0.0247	CcSEcCtD
Epinephrine—Disorientation—Lomustine—brain cancer	0.00236	0.0228	CcSEcCtD
Epinephrine—Cerebral haemorrhage—Carmustine—brain cancer	0.00209	0.0202	CcSEcCtD
Epinephrine—Cerebral haemorrhage—Temozolomide—brain cancer	0.00202	0.0195	CcSEcCtD
Epinephrine—Nephropathy—Etoposide—brain cancer	0.00188	0.0182	CcSEcCtD
Epinephrine—Renal failure—Lomustine—brain cancer	0.0016	0.0155	CcSEcCtD
Epinephrine—SLC22A1—ganglion—brain cancer	0.0016	0.0503	CbGeAlD
Epinephrine—Disorientation—Procarbazine—brain cancer	0.0015	0.0145	CcSEcCtD
Epinephrine—Necrosis—Carmustine—brain cancer	0.00147	0.0142	CcSEcCtD
Epinephrine—Haemoglobin—Lomustine—brain cancer	0.00147	0.0142	CcSEcCtD
Epinephrine—Haemorrhage—Lomustine—brain cancer	0.00146	0.0141	CcSEcCtD
Epinephrine—Memory impairment—Temozolomide—brain cancer	0.00142	0.0138	CcSEcCtD
Epinephrine—ADRBK1—telencephalon—brain cancer	0.00142	0.0447	CbGeAlD
Epinephrine—Skin exfoliation—Hydroxyurea—brain cancer	0.00137	0.0132	CcSEcCtD
Epinephrine—Extravasation—Carmustine—brain cancer	0.00133	0.0128	CcSEcCtD
Epinephrine—Pulmonary oedema—Hydroxyurea—brain cancer	0.00127	0.0123	CcSEcCtD
Epinephrine—Drug interaction—Carmustine—brain cancer	0.00125	0.0121	CcSEcCtD
Epinephrine—ADRBK1—gonad—brain cancer	0.00118	0.0373	CbGeAlD
Epinephrine—PAH—endocrine gland—brain cancer	0.00117	0.0369	CbGeAlD
Epinephrine—Disorientation—Hydroxyurea—brain cancer	0.00116	0.0112	CcSEcCtD
Epinephrine—PAH—head—brain cancer	0.00116	0.0364	CbGeAlD
Epinephrine—Necrosis—Etoposide—brain cancer	0.00114	0.011	CcSEcCtD
Epinephrine—Sweating increased—Procarbazine—brain cancer	0.00113	0.0109	CcSEcCtD
Epinephrine—Tingling sensation—Etoposide—brain cancer	0.00111	0.0108	CcSEcCtD
Epinephrine—Skin exfoliation—Carmustine—brain cancer	0.0011	0.0107	CcSEcCtD
Epinephrine—Skin exfoliation—Temozolomide—brain cancer	0.00107	0.0103	CcSEcCtD
Epinephrine—PAH—central nervous system—brain cancer	0.00105	0.0333	CbGeAlD
Epinephrine—Drowsiness—Procarbazine—brain cancer	0.00103	0.01	CcSEcCtD
Epinephrine—Extravasation—Etoposide—brain cancer	0.00102	0.00991	CcSEcCtD
Epinephrine—Sweating—Procarbazine—brain cancer	0.000991	0.00958	CcSEcCtD
Epinephrine—Haemoglobin—Procarbazine—brain cancer	0.000933	0.00902	CcSEcCtD
Epinephrine—Haemorrhage—Procarbazine—brain cancer	0.000928	0.00898	CcSEcCtD
Epinephrine—Hallucination—Procarbazine—brain cancer	0.000924	0.00893	CcSEcCtD
Epinephrine—ADRA1A—hindbrain—brain cancer	0.000922	0.0291	CbGeAlD
Epinephrine—ADRBK1—endocrine gland—brain cancer	0.000894	0.0282	CbGeAlD
Epinephrine—ADRBK1—head—brain cancer	0.000882	0.0278	CbGeAlD
Epinephrine—Flushing—Procarbazine—brain cancer	0.000861	0.00833	CcSEcCtD
Epinephrine—Skin exfoliation—Etoposide—brain cancer	0.000854	0.00826	CcSEcCtD
Epinephrine—PAH—brain—brain cancer	0.000838	0.0264	CbGeAlD
Epinephrine—Arrhythmia—Procarbazine—brain cancer	0.000829	0.00802	CcSEcCtD
Epinephrine—ADRA1D—telencephalon—brain cancer	0.000816	0.0257	CbGeAlD
Epinephrine—ADRBK1—central nervous system—brain cancer	0.000805	0.0254	CbGeAlD
Epinephrine—Drowsiness—Hydroxyurea—brain cancer	0.0008	0.00774	CcSEcCtD
Epinephrine—Tension—Procarbazine—brain cancer	0.000793	0.00767	CcSEcCtD
Epinephrine—ADRBK1—cerebellum—brain cancer	0.000787	0.0248	CbGeAlD
Epinephrine—Nervousness—Procarbazine—brain cancer	0.000785	0.00759	CcSEcCtD
Epinephrine—Hypokalaemia—Carmustine—brain cancer	0.000764	0.00739	CcSEcCtD
Epinephrine—Hypokalaemia—Temozolomide—brain cancer	0.000738	0.00714	CcSEcCtD
Epinephrine—Haemoglobin—Hydroxyurea—brain cancer	0.000722	0.00698	CcSEcCtD
Epinephrine—Haemorrhage—Hydroxyurea—brain cancer	0.000718	0.00695	CcSEcCtD
Epinephrine—Hallucination—Hydroxyurea—brain cancer	0.000715	0.00691	CcSEcCtD
Epinephrine—Hypertension—Procarbazine—brain cancer	0.000698	0.00675	CcSEcCtD
Epinephrine—Sweating increased—Temozolomide—brain cancer	0.000683	0.0066	CcSEcCtD
Epinephrine—Vomiting—Lomustine—brain cancer	0.00066	0.00639	CcSEcCtD
Epinephrine—Hyperglycaemia—Carmustine—brain cancer	0.000654	0.00633	CcSEcCtD
Epinephrine—Tachycardia—Procarbazine—brain cancer	0.000644	0.00622	CcSEcCtD
Epinephrine—ADRBK1—brain—brain cancer	0.000639	0.0202	CbGeAlD
Epinephrine—Hyperhidrosis—Procarbazine—brain cancer	0.000638	0.00616	CcSEcCtD
Epinephrine—Renal failure—Carmustine—brain cancer	0.000636	0.00615	CcSEcCtD
Epinephrine—Hyperglycaemia—Temozolomide—brain cancer	0.000632	0.00612	CcSEcCtD
Epinephrine—Erythema—Hydroxyurea—brain cancer	0.000625	0.00605	CcSEcCtD
Epinephrine—Nausea—Lomustine—brain cancer	0.000617	0.00597	CcSEcCtD
Epinephrine—SLC22A1—telencephalon—brain cancer	0.000616	0.0194	CbGeAlD
Epinephrine—Insomnia—Procarbazine—brain cancer	0.000596	0.00577	CcSEcCtD
Epinephrine—ADRB1—telencephalon—brain cancer	0.000593	0.0187	CbGeAlD
Epinephrine—Paraesthesia—Procarbazine—brain cancer	0.000592	0.00573	CcSEcCtD
Epinephrine—Somnolence—Procarbazine—brain cancer	0.000586	0.00567	CcSEcCtD
Epinephrine—Haemoglobin—Carmustine—brain cancer	0.000584	0.00564	CcSEcCtD
Epinephrine—Haemorrhage—Carmustine—brain cancer	0.000581	0.00562	CcSEcCtD
Epinephrine—Hallucination—Carmustine—brain cancer	0.000578	0.00559	CcSEcCtD
Epinephrine—Hypoaesthesia—Carmustine—brain cancer	0.000578	0.00559	CcSEcCtD
Epinephrine—Haemoglobin—Temozolomide—brain cancer	0.000564	0.00545	CcSEcCtD
Epinephrine—Haemorrhage—Temozolomide—brain cancer	0.000561	0.00543	CcSEcCtD
Epinephrine—Hypoaesthesia—Temozolomide—brain cancer	0.000558	0.0054	CcSEcCtD
Epinephrine—Hallucination—Temozolomide—brain cancer	0.000558	0.0054	CcSEcCtD
Epinephrine—Sweating increased—Etoposide—brain cancer	0.000547	0.00528	CcSEcCtD
Epinephrine—Flushing—Carmustine—brain cancer	0.000539	0.00521	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000529	0.00511	CcSEcCtD
Epinephrine—ADRA1A—brainstem—brain cancer	0.000528	0.0167	CbGeAlD
Epinephrine—Flushing—Temozolomide—brain cancer	0.000521	0.00504	CcSEcCtD
Epinephrine—ADRA1B—head—brain cancer	0.00052	0.0164	CbGeAlD
Epinephrine—Arrhythmia—Carmustine—brain cancer	0.000519	0.00502	CcSEcCtD
Epinephrine—ADRA1D—endocrine gland—brain cancer	0.000515	0.0162	CbGeAlD
Epinephrine—Mental disorder—Carmustine—brain cancer	0.000509	0.00492	CcSEcCtD
Epinephrine—ADRA1D—head—brain cancer	0.000508	0.016	CbGeAlD
Epinephrine—Erythema—Carmustine—brain cancer	0.000506	0.00489	CcSEcCtD
Epinephrine—Nervous system disorder—Hydroxyurea—brain cancer	0.000501	0.00484	CcSEcCtD
Epinephrine—Skin disorder—Hydroxyurea—brain cancer	0.000496	0.00479	CcSEcCtD
Epinephrine—Acute coronary syndrome—Etoposide—brain cancer	0.000493	0.00477	CcSEcCtD
Epinephrine—Renal failure—Etoposide—brain cancer	0.000492	0.00475	CcSEcCtD
Epinephrine—Mental disorder—Temozolomide—brain cancer	0.000492	0.00475	CcSEcCtD
Epinephrine—Myocardial infarction—Etoposide—brain cancer	0.00049	0.00474	CcSEcCtD
Epinephrine—Erythema—Temozolomide—brain cancer	0.000489	0.00472	CcSEcCtD
Epinephrine—ADRA1B—central nervous system—brain cancer	0.000474	0.015	CbGeAlD
Epinephrine—ADRA1A—telencephalon—brain cancer	0.000469	0.0148	CbGeAlD
Epinephrine—Agitation—Carmustine—brain cancer	0.000465	0.00449	CcSEcCtD
Epinephrine—ADRA1D—central nervous system—brain cancer	0.000464	0.0146	CbGeAlD
Epinephrine—Somnolence—Hydroxyurea—brain cancer	0.000454	0.00439	CcSEcCtD
Epinephrine—Agitation—Temozolomide—brain cancer	0.000449	0.00434	CcSEcCtD
Epinephrine—Hypoaesthesia—Etoposide—brain cancer	0.000447	0.00432	CcSEcCtD
Epinephrine—ADRA2C—telencephalon—brain cancer	0.000447	0.0141	CbGeAlD
Epinephrine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000441	0.00426	CcSEcCtD
Epinephrine—Hypertension—Carmustine—brain cancer	0.000436	0.00422	CcSEcCtD
Epinephrine—Dizziness—Procarbazine—brain cancer	0.000436	0.00422	CcSEcCtD
Epinephrine—Palpitations—Temozolomide—brain cancer	0.000432	0.00417	CcSEcCtD
Epinephrine—Chest pain—Carmustine—brain cancer	0.00043	0.00416	CcSEcCtD
Epinephrine—Hypertension—Temozolomide—brain cancer	0.000422	0.00408	CcSEcCtD
Epinephrine—Vomiting—Procarbazine—brain cancer	0.000419	0.00405	CcSEcCtD
Epinephrine—Flushing—Etoposide—brain cancer	0.000417	0.00403	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000413	0.00399	CcSEcCtD
Epinephrine—Tachycardia—Carmustine—brain cancer	0.000403	0.00389	CcSEcCtD
Epinephrine—Nausea—Procarbazine—brain cancer	0.000392	0.00379	CcSEcCtD
Epinephrine—Nervous system disorder—Temozolomide—brain cancer	0.000391	0.00378	CcSEcCtD
Epinephrine—SLC22A1—endocrine gland—brain cancer	0.000388	0.0122	CbGeAlD
Epinephrine—Skin disorder—Temozolomide—brain cancer	0.000387	0.00374	CcSEcCtD
Epinephrine—Hyperhidrosis—Temozolomide—brain cancer	0.000385	0.00373	CcSEcCtD
Epinephrine—SLC22A1—head—brain cancer	0.000383	0.0121	CbGeAlD
Epinephrine—ADRA1B—brain—brain cancer	0.000376	0.0119	CbGeAlD
Epinephrine—ADRB1—endocrine gland—brain cancer	0.000374	0.0118	CbGeAlD
Epinephrine—Insomnia—Carmustine—brain cancer	0.000373	0.00361	CcSEcCtD
Epinephrine—Paraesthesia—Carmustine—brain cancer	0.00037	0.00358	CcSEcCtD
Epinephrine—ADRB1—head—brain cancer	0.000369	0.0116	CbGeAlD
Epinephrine—ADRA1D—brain—brain cancer	0.000368	0.0116	CbGeAlD
Epinephrine—Somnolence—Carmustine—brain cancer	0.000367	0.00355	CcSEcCtD
Epinephrine—ADRA2C—pituitary gland—brain cancer	0.000364	0.0115	CbGeAlD
Epinephrine—Insomnia—Temozolomide—brain cancer	0.000361	0.00349	CcSEcCtD
Epinephrine—Paraesthesia—Temozolomide—brain cancer	0.000358	0.00346	CcSEcCtD
Epinephrine—ADRA2A—telencephalon—brain cancer	0.000356	0.0112	CbGeAlD
Epinephrine—Gastrointestinal disorder—Carmustine—brain cancer	0.000356	0.00344	CcSEcCtD
Epinephrine—Somnolence—Temozolomide—brain cancer	0.000354	0.00343	CcSEcCtD
Epinephrine—ADRA2C—medulla oblongata—brain cancer	0.000351	0.0111	CbGeAlD
Epinephrine—SLC22A1—central nervous system—brain cancer	0.00035	0.011	CbGeAlD
Epinephrine—SLC22A5—pituitary gland—brain cancer	0.000348	0.011	CbGeAlD
Epinephrine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000344	0.00333	CcSEcCtD
Epinephrine—Hypertension—Etoposide—brain cancer	0.000338	0.00326	CcSEcCtD
Epinephrine—Dizziness—Hydroxyurea—brain cancer	0.000338	0.00326	CcSEcCtD
Epinephrine—ADRB1—central nervous system—brain cancer	0.000337	0.0106	CbGeAlD
Epinephrine—SLC22A5—medulla oblongata—brain cancer	0.000336	0.0106	CbGeAlD
Epinephrine—Chest pain—Etoposide—brain cancer	0.000333	0.00322	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000331	0.0032	CcSEcCtD
Epinephrine—Vomiting—Hydroxyurea—brain cancer	0.000325	0.00314	CcSEcCtD
Epinephrine—ADRA2C—midbrain—brain cancer	0.000321	0.0101	CbGeAlD
Epinephrine—ADRA2C—spinal cord—brain cancer	0.000313	0.00987	CbGeAlD
Epinephrine—Tachycardia—Etoposide—brain cancer	0.000311	0.00301	CcSEcCtD
Epinephrine—Skin disorder—Etoposide—brain cancer	0.00031	0.003	CcSEcCtD
Epinephrine—Hyperhidrosis—Etoposide—brain cancer	0.000308	0.00298	CcSEcCtD
Epinephrine—SLC22A5—midbrain—brain cancer	0.000307	0.00969	CbGeAlD
Epinephrine—Nausea—Hydroxyurea—brain cancer	0.000303	0.00293	CcSEcCtD
Epinephrine—SLC22A5—spinal cord—brain cancer	0.0003	0.00945	CbGeAlD
Epinephrine—ADRA2A—gonad—brain cancer	0.000297	0.00938	CbGeAlD
Epinephrine—ADRA1A—endocrine gland—brain cancer	0.000296	0.00932	CbGeAlD
Epinephrine—ADRA1A—head—brain cancer	0.000292	0.0092	CbGeAlD
Epinephrine—ADRA2A—pituitary gland—brain cancer	0.00029	0.00915	CbGeAlD
Epinephrine—Paraesthesia—Etoposide—brain cancer	0.000286	0.00277	CcSEcCtD
Epinephrine—Somnolence—Etoposide—brain cancer	0.000284	0.00274	CcSEcCtD
Epinephrine—ADRA2A—medulla oblongata—brain cancer	0.00028	0.00883	CbGeAlD
Epinephrine—ADRA2C—head—brain cancer	0.000278	0.00877	CbGeAlD
Epinephrine—SLC22A1—brain—brain cancer	0.000278	0.00876	CbGeAlD
Epinephrine—Gastrointestinal disorder—Etoposide—brain cancer	0.000275	0.00266	CcSEcCtD
Epinephrine—Dizziness—Carmustine—brain cancer	0.000273	0.00264	CcSEcCtD
Epinephrine—ADRB1—brain—brain cancer	0.000268	0.00843	CbGeAlD
Epinephrine—ADRA1A—central nervous system—brain cancer	0.000266	0.0084	CbGeAlD
Epinephrine—Dizziness—Temozolomide—brain cancer	0.000264	0.00255	CcSEcCtD
Epinephrine—Vomiting—Carmustine—brain cancer	0.000262	0.00254	CcSEcCtD
Epinephrine—ADRA1A—cerebellum—brain cancer	0.00026	0.00821	CbGeAlD
Epinephrine—ADRA2A—midbrain—brain cancer	0.000256	0.00807	CbGeAlD
Epinephrine—ADRA2C—central nervous system—brain cancer	0.000254	0.008	CbGeAlD
Epinephrine—Vomiting—Temozolomide—brain cancer	0.000254	0.00245	CcSEcCtD
Epinephrine—ADRA2A—spinal cord—brain cancer	0.00025	0.00787	CbGeAlD
Epinephrine—ADRA2C—cerebellum—brain cancer	0.000248	0.00782	CbGeAlD
Epinephrine—Nausea—Carmustine—brain cancer	0.000245	0.00237	CcSEcCtD
Epinephrine—CYP1A2—endocrine gland—brain cancer	0.000244	0.00771	CbGeAlD
Epinephrine—SLC22A5—cerebellum—brain cancer	0.000238	0.00749	CbGeAlD
Epinephrine—Nausea—Temozolomide—brain cancer	0.000237	0.00229	CcSEcCtD
Epinephrine—CYP2C9—endocrine gland—brain cancer	0.000232	0.00732	CbGeAlD
Epinephrine—ADRA2A—endocrine gland—brain cancer	0.000225	0.00709	CbGeAlD
Epinephrine—ADRA2A—head—brain cancer	0.000222	0.007	CbGeAlD
Epinephrine—ADRA1A—brain—brain cancer	0.000212	0.00667	CbGeAlD
Epinephrine—Dizziness—Etoposide—brain cancer	0.000211	0.00204	CcSEcCtD
Epinephrine—Vomiting—Etoposide—brain cancer	0.000203	0.00196	CcSEcCtD
Epinephrine—ADRA2A—central nervous system—brain cancer	0.000203	0.00639	CbGeAlD
Epinephrine—ADRA2C—brain—brain cancer	0.000202	0.00635	CbGeAlD
Epinephrine—ADRA2A—cerebellum—brain cancer	0.000198	0.00624	CbGeAlD
Epinephrine—SLC22A5—brain—brain cancer	0.000193	0.00609	CbGeAlD
Epinephrine—Nausea—Etoposide—brain cancer	0.00019	0.00183	CcSEcCtD
Epinephrine—CYP3A4—endocrine gland—brain cancer	0.000177	0.00558	CbGeAlD
Epinephrine—ADRA2A—brain—brain cancer	0.000161	0.00507	CbGeAlD
Epinephrine—CYP3A4—central nervous system—brain cancer	0.000159	0.00503	CbGeAlD
Epinephrine—ADRA2C—Signaling Pathways—SMO—brain cancer	1.95e-05	0.000176	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—EGFR—brain cancer	1.95e-05	0.000176	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IRS2—brain cancer	1.95e-05	0.000175	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SMO—brain cancer	1.92e-05	0.000173	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PTCH1—brain cancer	1.92e-05	0.000173	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.91e-05	0.000172	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—PIK3CG—brain cancer	1.9e-05	0.000171	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—BSG—brain cancer	1.9e-05	0.000171	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—PIK3CG—brain cancer	1.9e-05	0.000171	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—PIK3CG—brain cancer	1.88e-05	0.00017	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—PIK3CG—brain cancer	1.86e-05	0.000168	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NOTCH2—brain cancer	1.85e-05	0.000167	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—STAT3—brain cancer	1.81e-05	0.000163	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SHH—brain cancer	1.8e-05	0.000162	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—VEGFA—brain cancer	1.78e-05	0.000161	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—EGFR—brain cancer	1.78e-05	0.00016	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—VAV1—brain cancer	1.76e-05	0.000159	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—PIK3CG—brain cancer	1.76e-05	0.000158	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TRPC6—brain cancer	1.74e-05	0.000156	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—PIK3CG—brain cancer	1.73e-05	0.000156	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—PIK3CG—brain cancer	1.73e-05	0.000156	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—APC—brain cancer	1.72e-05	0.000155	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—PIK3CG—brain cancer	1.72e-05	0.000155	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—PIK3CG—brain cancer	1.71e-05	0.000154	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SMO—brain cancer	1.71e-05	0.000154	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PTCH1—brain cancer	1.71e-05	0.000154	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—PIK3CG—brain cancer	1.69e-05	0.000152	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NOTCH2—brain cancer	1.69e-05	0.000152	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—MYC—brain cancer	1.68e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—RELA—brain cancer	1.67e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SHH—brain cancer	1.67e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NOTCH2—brain cancer	1.67e-05	0.00015	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—VEGFA—brain cancer	1.67e-05	0.00015	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—ERBB2—brain cancer	1.66e-05	0.00015	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NOTCH2—brain cancer	1.65e-05	0.000148	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—EGFR—brain cancer	1.65e-05	0.000148	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—IDH1—brain cancer	1.63e-05	0.000147	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—BSG—brain cancer	1.62e-05	0.000146	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TRPC6—brain cancer	1.61e-05	0.000145	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—VAV1—brain cancer	1.61e-05	0.000145	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—PIK3CG—brain cancer	1.6e-05	0.000144	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—VAV1—brain cancer	1.59e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—IL2—brain cancer	1.59e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SMO—brain cancer	1.59e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PTCH1—brain cancer	1.59e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—PIK3CG—brain cancer	1.57e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—VAV1—brain cancer	1.57e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—EGFR—brain cancer	1.57e-05	0.000141	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NOTCH2—brain cancer	1.56e-05	0.00014	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	1.54e-05	0.000139	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NOTCH2—brain cancer	1.54e-05	0.000138	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—HES1—brain cancer	1.52e-05	0.000137	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—IL2—brain cancer	1.51e-05	0.000136	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—VAV1—brain cancer	1.49e-05	0.000134	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.47e-05	0.000133	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—IL2—brain cancer	1.47e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—CCND1—brain cancer	1.47e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—VAV1—brain cancer	1.46e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—CTNNB1—brain cancer	1.45e-05	0.000131	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PDGFRA—brain cancer	1.44e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	1.43e-05	0.000129	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—SPP1—brain cancer	1.4e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	1.4e-05	0.000126	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—IDH1—brain cancer	1.4e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—HES1—brain cancer	1.38e-05	0.000124	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—HES1—brain cancer	1.37e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	1.36e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—VEGFA—brain cancer	1.35e-05	0.000122	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—HES1—brain cancer	1.35e-05	0.000122	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—TP53—brain cancer	1.35e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—RELA—brain cancer	1.34e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—IL2—brain cancer	1.34e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—ERBB2—brain cancer	1.33e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL2—brain cancer	1.33e-05	0.00012	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.33e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—IL2—brain cancer	1.33e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PDGFRA—brain cancer	1.32e-05	0.000118	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—IL2—brain cancer	1.31e-05	0.000118	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PDGFRA—brain cancer	1.3e-05	0.000117	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—VAV1—brain cancer	1.3e-05	0.000117	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	1.3e-05	0.000117	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ENO2—brain cancer	1.29e-05	0.000116	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PDGFRA—brain cancer	1.29e-05	0.000116	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—VEGFA—brain cancer	1.28e-05	0.000115	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—HES1—brain cancer	1.28e-05	0.000115	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—SPP1—brain cancer	1.28e-05	0.000115	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—STAT3—brain cancer	1.27e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IRS2—brain cancer	1.27e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	1.27e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—SPP1—brain cancer	1.27e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—HES1—brain cancer	1.26e-05	0.000113	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—TP53—brain cancer	1.26e-05	0.000113	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—BSG—brain cancer	1.25e-05	0.000113	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—SPP1—brain cancer	1.25e-05	0.000113	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—IL2—brain cancer	1.24e-05	0.000112	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—IL2—brain cancer	1.22e-05	0.00011	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PDGFRA—brain cancer	1.22e-05	0.00011	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL2—brain cancer	1.22e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL2—brain cancer	1.21e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VAV1—brain cancer	1.21e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL2—brain cancer	1.2e-05	0.000108	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	1.2e-05	0.000108	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL2—brain cancer	1.19e-05	0.000107	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SPP1—brain cancer	1.18e-05	0.000106	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CCND1—brain cancer	1.18e-05	0.000106	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—MYC—brain cancer	1.18e-05	0.000106	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CTNNB1—brain cancer	1.17e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SPP1—brain cancer	1.16e-05	0.000105	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PIK3CG—brain cancer	1.16e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IRS2—brain cancer	1.16e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—EGFR—brain cancer	1.15e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IRS2—brain cancer	1.14e-05	0.000103	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.14e-05	0.000102	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IRS2—brain cancer	1.13e-05	0.000102	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PIK3CG—brain cancer	1.13e-05	0.000102	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL2—brain cancer	1.12e-05	0.000101	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	1.12e-05	0.000101	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—APC—brain cancer	1.12e-05	0.000101	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—HES1—brain cancer	1.12e-05	0.000101	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL2—brain cancer	1.11e-05	9.97e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ENO2—brain cancer	1.1e-05	9.94e-05	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—IL2—brain cancer	1.08e-05	9.75e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PIK3CG—brain cancer	1.08e-05	9.74e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—IDH1—brain cancer	1.08e-05	9.7e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IRS2—brain cancer	1.07e-05	9.63e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	1.06e-05	9.59e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IRS2—brain cancer	1.05e-05	9.47e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HES1—brain cancer	1.04e-05	9.35e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SPP1—brain cancer	1.03e-05	9.31e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—VEGFA—brain cancer	1.03e-05	9.26e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TP53—brain cancer	1.02e-05	9.2e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—APC—brain cancer	1.02e-05	9.19e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PIK3CG—brain cancer	1.02e-05	9.19e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—EGFR—brain cancer	1.02e-05	9.19e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—STAT3—brain cancer	1.02e-05	9.16e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	1.01e-05	9.1e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—APC—brain cancer	1.01e-05	9.1e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—IL2—brain cancer	1.01e-05	9.06e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—APC—brain cancer	9.98e-06	8.99e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PIK3CG—brain cancer	9.98e-06	8.99e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	9.89e-06	8.91e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL2—brain cancer	9.83e-06	8.85e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TP53—brain cancer	9.67e-06	8.71e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SPP1—brain cancer	9.6e-06	8.65e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MYC—brain cancer	9.46e-06	8.52e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	9.44e-06	8.5e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—APC—brain cancer	9.44e-06	8.5e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IRS2—brain cancer	9.35e-06	8.42e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—EGFR—brain cancer	9.3e-06	8.37e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—APC—brain cancer	9.29e-06	8.37e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	9.29e-06	8.37e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—EGFR—brain cancer	9.25e-06	8.33e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—EGFR—brain cancer	9.21e-06	8.29e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PIK3CG—brain cancer	9.17e-06	8.26e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL2—brain cancer	9.14e-06	8.23e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—EGFR—brain cancer	9.09e-06	8.19e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—RELA—brain cancer	8.75e-06	7.88e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—ERBB2—brain cancer	8.69e-06	7.83e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IRS2—brain cancer	8.68e-06	7.82e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—EGFR—brain cancer	8.6e-06	7.75e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ENO2—brain cancer	8.52e-06	7.67e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—EGFR—brain cancer	8.47e-06	7.62e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	8.25e-06	7.43e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—APC—brain cancer	8.25e-06	7.43e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—RELA—brain cancer	7.97e-06	7.18e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—ERBB2—brain cancer	7.92e-06	7.13e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—RELA—brain cancer	7.9e-06	7.11e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL2—brain cancer	7.88e-06	7.09e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—ERBB2—brain cancer	7.85e-06	7.07e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—RELA—brain cancer	7.8e-06	7.02e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TP53—brain cancer	7.77e-06	6.99e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—ERBB2—brain cancer	7.75e-06	6.98e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCND1—brain cancer	7.68e-06	6.92e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	7.67e-06	6.91e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—APC—brain cancer	7.67e-06	6.91e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	7.61e-06	6.85e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	7.52e-06	6.77e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—RELA—brain cancer	7.38e-06	6.64e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—ERBB2—brain cancer	7.33e-06	6.6e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—RELA—brain cancer	7.26e-06	6.54e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—ERBB2—brain cancer	7.22e-06	6.5e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL2—brain cancer	7.18e-06	6.46e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL2—brain cancer	7.11e-06	6.41e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL2—brain cancer	7.02e-06	6.32e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCND1—brain cancer	7e-06	6.3e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—EGFR—brain cancer	6.99e-06	6.29e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCND1—brain cancer	6.93e-06	6.24e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CTNNB1—brain cancer	6.93e-06	6.24e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	6.87e-06	6.18e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCND1—brain cancer	6.85e-06	6.16e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CTNNB1—brain cancer	6.78e-06	6.1e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—VEGFA—brain cancer	6.7e-06	6.03e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL2—brain cancer	6.65e-06	5.98e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—STAT3—brain cancer	6.63e-06	5.97e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL2—brain cancer	6.54e-06	5.89e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCND1—brain cancer	6.48e-06	5.83e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—RELA—brain cancer	6.45e-06	5.81e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	6.41e-06	5.78e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	6.41e-06	5.77e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCND1—brain cancer	6.38e-06	5.74e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	6.31e-06	5.68e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MYC—brain cancer	6.16e-06	5.55e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—VEGFA—brain cancer	6.1e-06	5.49e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—VEGFA—brain cancer	6.05e-06	5.44e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—STAT3—brain cancer	6.04e-06	5.44e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—EGFR—brain cancer	6.03e-06	5.43e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—RELA—brain cancer	5.99e-06	5.4e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—STAT3—brain cancer	5.99e-06	5.39e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—VEGFA—brain cancer	5.97e-06	5.37e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ERBB2—brain cancer	5.96e-06	5.36e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CG—brain cancer	5.93e-06	5.34e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—STAT3—brain cancer	5.91e-06	5.32e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL2—brain cancer	5.81e-06	5.23e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCND1—brain cancer	5.66e-06	5.1e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—VEGFA—brain cancer	5.65e-06	5.08e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MYC—brain cancer	5.61e-06	5.05e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	5.61e-06	5.05e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—STAT3—brain cancer	5.59e-06	5.03e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MYC—brain cancer	5.56e-06	5.01e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—VEGFA—brain cancer	5.56e-06	5e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—STAT3—brain cancer	5.5e-06	4.96e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MYC—brain cancer	5.49e-06	4.94e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—EGFR—brain cancer	5.49e-06	4.94e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—EGFR—brain cancer	5.44e-06	4.9e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL2—brain cancer	5.4e-06	4.86e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—EGFR—brain cancer	5.37e-06	4.84e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCND1—brain cancer	5.26e-06	4.74e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	5.21e-06	4.69e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MYC—brain cancer	5.2e-06	4.68e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MYC—brain cancer	5.11e-06	4.6e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—EGFR—brain cancer	5.08e-06	4.58e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CG—brain cancer	5.06e-06	4.56e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—brain cancer	5.06e-06	4.56e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—EGFR—brain cancer	5e-06	4.5e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	4.94e-06	4.45e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—STAT3—brain cancer	4.89e-06	4.4e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—brain cancer	4.61e-06	4.15e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VEGFA—brain cancer	4.59e-06	4.13e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—brain cancer	4.57e-06	4.11e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MYC—brain cancer	4.54e-06	4.09e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—STAT3—brain cancer	4.54e-06	4.09e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—brain cancer	4.51e-06	4.06e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—EGFR—brain cancer	4.44e-06	4e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—brain cancer	4.27e-06	3.84e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MYC—brain cancer	4.22e-06	3.8e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—brain cancer	4.2e-06	3.78e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—EGFR—brain cancer	4.13e-06	3.72e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CG—brain cancer	3.91e-06	3.52e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—brain cancer	3.73e-06	3.36e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—brain cancer	3.47e-06	3.12e-05	CbGpPWpGaD
